Medpace General and Financial
Code of Ethics
Effective Date: 10-OCT-2009
All Medpace employees, officers, and directors are held to the highest standards
of ethical behavior in all business dealings and must fully comply with all applicable
laws and with this Code. Honesty, confidentiality, integrity, and adherence to Standard
Operating Procedures (SOPs) and applicable regulatory guidelines are our governing
principles. All are held accountable for their actions and are required to report
unethical or unlawful activities as well as any violations of this Code. Anyone
who violates this Code is subject to disciplinary action, which may include termination
of employment and/or legal action.
-
The CEO, CFO, Controller, and all other members of the Medpace management team are
responsible for working within their respective areas of responsibility to ensure
that the Company operates in compliance with all applicable laws, rules, and regulations
that govern the conduct of the company’s business worldwide. They are also responsible
for promoting honest and ethical conduct including recognizing actual or potential
conflicts of interest amongst themselves and others and for taking appropriate action
to prevent collusion and inappropriate or unlawful financial transactions.
-
All employees will work to ensure that financial information and all other public
communications are reported completely, honestly, accurately, timely, and in an
understandable manner.
-
All employees are responsible for understanding and complying with all applicable
company policies and SOPs.
-
Open communication is encouraged throughout the organization.
-
Confidential information should be disclosed only when authorized or required.
-
The Board of Directors is responsible for considering any request for a waiver of
or amendment to this code. Any waiver or amendment must receive a supermajority
vote (at least 66%) of all directors for approval. All waivers or amendments should
be disclosed to shareholders in a timely manner as provided by law.
-
Any violation of this Code or applicable law must be reported to the Corporate Compliance
Officer; however, incidents involving suspected or actual financial wrongdoing may be reported
to the Chairman of the Audit Committee of the Board of Directors instead of, or in addition to,
the Corporate Compliance Officer. Contact information for the Corporate Compliance Officer and
the Audit Committee Chair is available below. Each report will be investigated and findings
will be provided to the Board of Directors. Reports may be made anonymously and without fear of
retribution.
Chair of the Audit Committee
Paul Sobel
Vice President – Internal Audit
Mirant Corporation
1155 Perimeter Circle West
Atlanta, Georgia 30338
Tel: +1.678.579.5042
E-mail: paul.sobel@mirant.com
Corporate Compliance Officer
Kay Nolen
General Counsel & Corporate Secretary
Medpace Corporate Headquarters
4620 Wesley Avenue
Cincinnati, Ohio 45212, USA
Office #2821
Tel: +1.513.579.9911, ext. 2055
Fax: +1.513.579.0444
E-mail: compliance@medpace.com